Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 11.12% is 47% above its 5-year average of 7.57%, near the high end of its 5-year range (-103.03%–13.58%).
0.27% above its 12-month average of 11.09%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-07-04): 11.93%.
OPERATING MARGIN
11.12%
OPERATING MARGIN AVG TTM
11.09%
OPERATING MARGIN AVG 3Y
9.17%
OPERATING MARGIN AVG 5Y
7.57%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+0.27%
CURRENT VS 3Y AVG
+21.33%
CURRENT VS 5Y AVG
+46.87%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 431 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Aveanna Healthcare Holdings Inc.
Market Cap
$2.69B
Operating Margin
11.12%
TTM Avg
11.09%
3Y Avg
9.17%
5Y Avg
7.57%
Market Cap
$2.69B
Operating Margin
10.06%
TTM Avg
14.13%
3Y Avg
15.87%
5Y Avg
13.57%
Market Cap
$2.64B
Operating Margin
-42.22%
TTM Avg
-21.11%
3Y Avg
-21.11%
5Y Avg
-21.11%
Market Cap
$2.64B
Operating Margin
-274.57%
TTM Avg
-464.41%
3Y Avg
-382.79%
5Y Avg
-92575.80%
Market Cap
$2.87B
Operating Margin
12.21%
TTM Avg
13.21%
3Y Avg
-4.78%
5Y Avg
-42.05%
Market Cap
$2.51B
Operating Margin
-867.87%
TTM Avg
-840.98%
3Y Avg
-774.76%
5Y Avg
-1234.34%
Market Cap
$2.88B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.43B
Operating Margin
-0.74%
TTM Avg
-3.89%
3Y Avg
-12.55%
5Y Avg
-17.88%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aveanna Healthcare Holdings Inc. (AVAH) | $2.69B | 11.12% | 11.09% | 9.17% | 7.57% |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.69B | 10.06% | 14.13% | 15.87% | 13.57% |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.64B | -42.22% | -21.11% | -21.11% | -21.11% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.64B | -274.57% | -464.41% | -382.79% | -92575.80% |
| AtriCure, Inc. (ATRC)vs › | $2.87B | 2.44% | -4.62% | -7.21% | -5.02% |
| TransMedics Group, Inc. (TMDX)vs › | $2.87B | 12.21% | 13.21% | -4.78% | -42.05% |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.51B | -867.87% | -840.98% | -774.76% | -1234.34% |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.88B | 0.00% | 0.00% | 0.00% | 0.00% |
| Clover Health Investments, Corp. (CLOV)vs › | $2.43B | -0.74% | -3.89% | -12.55% | -17.88% |
| ADMA Biologics, Inc. (ADMA)vs › | $2.34B | 42.26% | 35.06% | 13.24% | -28.82% |
Gross Margin
31.9%
Operating Margin
11.1%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-07-04 | 11.93% |
| 2026-04-04 | 11.72% |
| 2026-01-03 | 11.66% |
| 2025-09-27 | 9.05% |
| 2025-06-28 | 13.58% |
| 2025-03-29 | 9.26% |
| 2024-12-28 | 8.80% |
| 2024-09-28 | 6.68% |
| 2024-06-29 | 7.35% |
| 2024-03-30 | 4.66% |
| 2023-12-30 | 6.12% |
| 2023-09-30 | -15.97% |
| 2023-07-01 | 7.94% |
| 2023-04-01 | 3.78% |
| 2022-12-31 | -45.32% |
| 2022-10-01 | 1.08% |
| 2022-07-02 | -103.03% |
| 2022-04-02 | 3.06% |
| 2022-01-01 | -27.30% |
| 2021-10-02 | 4.46% |
| 2021-07-03 | 6.95% |
| 2021-04-03 | 6.78% |
| 2020-12-31 | 4.20% |
| 2020-09-30 | 3.52% |
| 2020-06-30 | -14.78% |
| 2020-03-31 | 5.03% |
